Zobrazeno 1 - 10
of 12
pro vyhledávání: '"François Dievart"'
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-14 (2023)
Abstract Due to their cardiovascular protective effect, glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) represent breakthrough therapies for type 2 diabetes mellitus (T2DM). In this review
Externí odkaz:
https://doaj.org/article/6420101921534b9f9d011a67767b1819
Autor:
Theodora Bejan-Angoulvant, Walid Darwiche, Denis Angoulvant, Laurent Fauchier, François Dievart, Dominique Babuty
Publikováno v:
International Journal of Cardiology. 206:89-92
Publikováno v:
European Heart Journal
European Heart Journal, 2016, 37 (5), pp.494--495. ⟨10.1093/eurheartj/ehv528⟩
European Heart Journal, Oxford University Press (OUP): Policy B, 2016, 37 (5), pp.494--495. ⟨10.1093/eurheartj/ehv528⟩
European Heart Journal, 2016, 37 (5), pp.494--495. ⟨10.1093/eurheartj/ehv528⟩
European Heart Journal, Oxford University Press (OUP): Policy B, 2016, 37 (5), pp.494--495. ⟨10.1093/eurheartj/ehv528⟩
This editorial refers to ‘Peri-infarct zone pacing to prevent adverse left ventricular remodelling in patients with large myocardial infarction’, by G.W. Stone et al ., on page doi:10.1093/eurheartj/ehv436. The management of acute ST-segment elev
Autor:
Dimitrios Richter, Luigina Guasti, Friedrich Koehler, Alessandro Squizzato, Stefano Nistri, Ruxandra Christodorescu, Francois Dievart, Giovanni Gaudio, Riccardo Asteggiano, Marc Ferrini
Publikováno v:
ESC Heart Failure, Vol 8, Iss 5, Pp 3483-3494 (2021)
Abstract Cardiovascular (CV) engagement in coronavirus disease 2019 (COVID‐19) is a huge determinant of prognosis during the acute phase of the disease. However, little is known about the potential chronic implications of the late phase of COVID‐
Externí odkaz:
https://doaj.org/article/693055d8cd294b7f8005e6cfdcd27a5a
Autor:
François Dievart, Gilles Errieau, Jean-François Aupetit, Albert Hagège, Jean-Jacques Mourad, Nacima Demil
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 2(1)
While the links between high blood pressure and heart failure (HF) are well known, the clinical profiles of hypertensive patients (pts) according to measure of left ventricular (LV) ejection fraction (EF) remain poorly investigated. O-PREDICT 2 was a
Autor:
George Pisica-Donose, François Dievart, Yves Cottin, Nicolas Danchin, Marie Helene Barlet, Serge Kownator, Pascal Priollet, Jean Ferrière
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 2(1)
Background In ACS patients, presence of a peripheral arterial disease (PAD) or a low ankle brachial index (ABI) is associated with a higher CV risk in either symptomatic or asymptomatic PAD patients than ACS patients without PAD. Objective To determi
Autor:
Nacima Demil, Albert Hagège, François Dievart, Jean-Jacques Mourad, Gilles Errieau, Jean-François Aupetit
Publikováno v:
Archives of cardiovascular diseases. 103(3)
SummaryBackgroundRoutine management of hypertensive adults is based on assessment of risk factors for coronary artery disease; risk factors for heart failure (HF) remain poorly investigated despite the key role of hypertension in HF development.AimTo
Autor:
Jean-François Thébaut, M.A. Herrmann, Olivier Grenier, Esvet Mihci, Jean Ferrières, François Dievart, Nicolas Danchin
Publikováno v:
International journal of cardiology. 133(1)
Background We evaluated correlates of prolonged use of evidence-based therapies in patients discharged after non-ST-segment elevation acute coronary syndrome (NSTE ACS). Methods 598 cardiologists enrolled 2443 patients at outpatient clinics 2–12 mo
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 2:38
Background Few data are available about real life and management of patients heart failure with preserved systolic function (HF-PSF). Objective To describe patients, disease characteristics and treatment strategies implemented in HF-PSF patients hosp
Publikováno v:
Archives of Cardiovascular Diseases. (4):236-244
SummaryBackgroundThe rate of uncontrolled hypertensives aged >80 years is not well known. The available literature on this topic has used the threshold80 years, but when the target is not reached they are less likely to increase treatment if DBP is